Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Photodynamic therapy for thoracic malignancies.

H I Pass1, H Pogrebniak

  • 1Surgery Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892.

Seminars in Surgical Oncology
|July 1, 1992
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Inhibition of the spindle assembly checkpoint kinase Mps-1 as a novel therapeutic strategy in malignant mesothelioma.

Oncogene·2017
Same author

Minimal asbestos exposure in germline BAP1 heterozygous mice is associated with deregulated inflammatory response and increased risk of mesothelioma.

Oncogene·2015
Same author

Aspirin delays mesothelioma growth by inhibiting HMGB1-mediated tumor progression.

Cell death & disease·2015
Same author

Autocrine CSF-1R signaling drives mesothelioma chemoresistance via AKT activation.

Cell death & disease·2014
Same author

Expression profiling stratifies mesothelioma tumors and signifies deregulation of spindle checkpoint pathway and microtubule network with therapeutic implications.

Annals of oncology : official journal of the European Society for Medical Oncology·2014
Same author

Protumorigenic effects of mir-145 loss in malignant pleural mesothelioma.

Oncogene·2013

Photodynamic therapy (PDT) uses light-activated drugs to destroy cancer cells, offering a targeted treatment for various tumors. This experimental therapy shows promise, particularly as an adjunct for pleural malignancies like mesothelioma.

Area of Science:

  • Oncology
  • Photochemistry

Background:

  • Photodynamic therapy (PDT) is an experimental cancer treatment.
  • It utilizes photoactivation of a sensitizing chemical with specific light wavelengths.
  • This process generates toxic oxygen species for localized cancer destruction.

Purpose of the Study:

  • To evaluate the efficacy of PDT in cancer treatment.
  • To explore its application in managing endobronchial obstruction.
  • To assess PDT as a surgical adjunct for pleural malignancies, including mesothelioma.

Main Methods:

  • Employing photoactivation of sensitizing chemicals.
  • Utilizing light of a specific wavelength.
  • Leveraging selective sensitizer retention in malignant tissues.

Related Experiment Videos

Main Results:

  • PDT causes local tumor destruction through direct tumoricidal effects.
  • It induces hemorrhagic necrosis of tumor tissue via indirect effects on vasculature.
  • PDT has been used for endobronchial obstruction and is being trialed for mesothelioma.

Conclusions:

  • PDT is a promising experimental cancer therapy with dual mechanisms of action.
  • Its selective action on malignant tissue offers a therapeutic advantage.
  • Ongoing trials suggest potential for PDT in treating pleural malignancies like mesothelioma.